Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biotech
biotech
Biopharma’s top 5 IPOs of 2023 (so far)
Biopharma’s top 5 IPOs of 2023 (so far)
Pharma Voice
biotech
IPOs
Acelyrin
Apogee Therapeutics
RayzeBio
Neumora Therapeutics
Mineralys Therapeutics
Flag link:
CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’
CEO Anne Wojcicki on turning 23andMe into a ‘full-fledged biotech’
BioPharma Dive
23andMe
biotech
Anne Wojcicki
Flag link:
Flagship expands into Asia-Pacific with new Singapore hub
Flagship expands into Asia-Pacific with new Singapore hub
BioPharma Dive
Flagship Pioneering
biotech
Singapore
Flag link:
XBI biotech index rises, giving investors a shred of hope
XBI biotech index rises, giving investors a shred of hope
Stat
biotech
XBI index
Flag link:
Why The Next Blockbuster Therapy May Come Out Of Singapore
Why The Next Blockbuster Therapy May Come Out Of Singapore
Forbes
Singapore
Biopolis
biotech
Flag link:
The 2023 Biotech Graveyard
The 2023 Biotech Graveyard
Fierce Biotech
biotech
Rubius Therapeutics
Nabriva Therapeutics
Calithera Biosciences
Goldfinch Bio
Antios Therapeutics
Magenta Therapeutics
Coda Biotherapeutics
Aristea Therapeutics
Flag link:
Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024
Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024
BioPharma Dive
biotech
funding
IPOs
Flag link:
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
Fierce Biotech
BIO
biotech
funding
Inflation Reduction Act
Flag link:
Biotech Accelerator Debuts in Houston
Biotech Accelerator Debuts in Houston
BioSpace
biotech
accelerators
Houston
Texas
Rice University
Flag link:
A decade later, biotech’s CRISPR revolution is still going strong
A decade later, biotech’s CRISPR revolution is still going strong
BioPharma Dive
CRISPR
gene editing
biotech
Flag link:
Massachusetts Biopharma Job Growth Surpasses that of Other States: Report
Massachusetts Biopharma Job Growth Surpasses that of Other States: Report
BioSpace
Massachusetts
R&D
biotech
biotech hubs
Flag link:
Biotech Bankruptcies Skyrocket
Biotech Bankruptcies Skyrocket
BioSpace
biotech
bankruptcy
Athenex
Aceragen
Avadel Specialty Pharmaceuticals
NephroGenex
Sancilio Pharmaceuticals
Statera Biopharma
Flag link:
After pandemic sugar rush, a market 'hangover' opens biotech to funding approaches steeped in stigma
After pandemic sugar rush, a market 'hangover' opens biotech to funding approaches steeped in stigma
Fierce Biotech
biotech
funding
venture capital
Flag link:
How biotech IPOs performed in the third quarter
How biotech IPOs performed in the third quarter
BioPharma Dive
biotech
IPOs
Adlai Nortye
RayzeBio
Neumora Therapeutics
Mira Pharmaceuticals
Turnstone Biologics
Apogee Therapeutics
Sagimet Biosciences
60 Degrees Pharma
Flag link:
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
‘It’s Like Ross Was Planning This Project.’ Perot Sr.’s HQ Finds New Life as Biotech Development
‘It’s Like Ross Was Planning This Project.’ Perot Sr.’s HQ Finds New Life as Biotech Development
D Magazine
biotech
Texas
NexPoint
Flag link:
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Vivek Ramaswamy’s brashness made waves in the Republican debate. He did the same in biotech
Stat
Vivek Ramaswamy
2024 Presidential election
biotech
Roivant
Flag link:
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Mass Layoffs Continue Across The Biotech Sector. What Does This Mean For Pharma’s Future?
Forbes
biotech
layoffs
Flag link:
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Are biotech VCs headed for better times? In one firm’s success, lessons for turning crisis into profit
Stat
biotech
funding
venture capital
The Column Group
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »